Results 101 to 110 of about 33,694 (186)

Proceedings 35th Symposium ESVN‐ECVN

open access: yes
Journal of Veterinary Internal Medicine, Volume 39, Issue 2, March/April 2025.
wiley   +1 more source

Detection of a streptogramin A O-acetyltransferase gene (vatD) in the chromosome of Clostridium botulinum isolated from infants in the United States

open access: yesApplied and Environmental Microbiology
Infant botulism, the most common form of botulism in the United States, occurs when botulinum toxin-producing clostridia colonize the infant’s gut and produce botulinum neurotoxin (BoNT).
Ana Rafaela Kruemmel   +4 more
doaj   +1 more source

Botulism Outbreak in a Family after Ingestion of Locally Produced Cheese

open access: yesIranian Journal of Medical Sciences, 2017
Botulism is one of the most important foodborne diseases and is caused by Clostridium botulinum toxin. The main manifestations are flaccid muscle paralysis and cranial nerve palsies.
Shahram Rafie   +3 more
doaj  

Iatrogenic botulism cases after gastric and axillary application of botulinum toxin and review of literature

open access: yesJournal of Infection in Developing Countries
Introduction: Iatrogenic botulism is a rare, serious disease that progresses with descending paralysis and develops after cosmetic or therapeutic botulinum toxin-A (BoNT-A) application.
Fatma Eser   +6 more
doaj   +1 more source

Standardization of the Japanese National Standard, Equine Botulinum Antitoxin Type A, and Factors Affecting Standardization

open access: yesJapanese Journal of Infectious Diseases
Equine botulinum antitoxin is one of the most popular countermeasures for human botulism. The unitage of the antitoxin product is defined according to national minimum requirement or pharmacopoeia in each country by referring to national standard antitoxins for four types (A, B, E, and F). With the expected depletion of the national standard antitoxins,
Yutani, Masahiro   +4 more
openaire   +2 more sources

A sensitive cell-based assay for testing potency of Botulinum neurotoxin type A [PDF]

open access: yes
Botulinum neurotoxin type A (BoNT/A) is a biopharmaceutic widely used for the treatment of neu­rological diseases and in aesthetic medicine to achieve months-long paralysis of target muscles and glands.
Peden, A.A.   +13 more
core   +1 more source

Design and evaluation of mRNA encoding recombinant neutralizing antibodies for botulinum neurotoxin type B intoxication prophylaxis

open access: yesHuman Vaccines & Immunotherapeutics
Among all natural and synthetic toxins, botulinum neurotoxins (BoNTs), produced by Clostridium botulinum in an anaerobic environment, are the most toxic polymer proteins.
Gulisaina Qiaerxie   +8 more
doaj   +1 more source

Google Trends as a Sentinel for Foodborne Botulism: Lessons in Early Diagnosis and Treatment

open access: yesDissertation Nursing
  The suspected foodborne botulism outbreak reported in Southern Italy in August 2025 generated a marked increase in public interest, reflected by a sharp rise in Google Trends searches related to botulism.
Gian Domenico Giusti   +4 more
doaj   +1 more source

A BEVERAGE-BORNE ATTACK WITH BOTULINUM TOXIN

open access: yes, 2019
Terrorists contaminated beer tanks of an amusement park supply chain with Botulinum toxin. The amusement park delivers beer to its restaurants and coffee shops by a pipeline network supplied from beer tanks which are fed by tanker-trucks. There are 30000
Chen, Wanying, Guinet, A.
core   +2 more sources

Capsaicin protects neuromuscular junctions from the inhibitory effects of botulinum neurotoxin A [PDF]

open access: yes, 2008
Within 24 hrs after injecting botulinum neurotoxin A (BoNT/A) into the hindlimb, mice lost the toe spread reflex and developed progressive muscle weakness. At the same time, the compound muscle action potential amplitude decreased. Injection of capsaicin
Carmen Garcia   +5 more
core  

Home - About - Disclaimer - Privacy